Viewing Study NCT00849732


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2025-12-31 @ 2:46 AM
Study NCT ID: NCT00849732
Status: COMPLETED
Last Update Posted: 2015-02-27
First Post: 2009-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module